Paliperidone palmitate contains not less than 98.0% and not more than 102.0% of C39H57FN4O4, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

噁唑嘧酮棕櫚酸酯(無菌)
Paliperidone palmitate (sterile)

• 申請商: 東譽興業股份有限公司
• 適應症: 抗精神病藥
• 發證日期: 2024-09-03